High Tower Advisors, LLC Agenus Inc Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.63 - $1.14 $38,297 - $69,300	-60,790 Reduced 14.34%	363,065 $301,000
Q3 2023 Nov 08, 2023	SELL	$1.12 - $1.88 $31,232 - $52,425	-27,886 Reduced 6.17%	423,855 $478,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $44,914 - $69,943	34,286 Added 8.21%	451,741 $722,000
Q1 2023 May 11, 2023	BUY	$1.45 - $2.95 $10,232 - $20,818	7,057 Added 1.72%	417,455 $634,000
Q4 2022 Feb 08, 2023	BUY	$2.02 - $3.25 $17,343 - $27,904	8,586 Added 2.14%	410,398 $984,000
Q3 2022 Nov 09, 2022	SELL	$1.96 - $3.14 $66,151 - $105,978	-33,751 Reduced 7.75%	401,812 $823,000
Q2 2022 Aug 10, 2022	BUY	$1.3 - $2.64 $89,169 - $181,082	68,592 Added 18.69%	435,563 $840,000
Q1 2022 May 12, 2022	BUY	$2.35 - $3.47 $1,882 - $2,779	801 Added 0.22%	366,971 $898,000
Q4 2021 Feb 10, 2022	BUY	$2.92 - $5.74 $162,261 - $318,966	55,569 Added 17.89%	366,170 $1.18 Million
Q3 2021 Nov 12, 2021	SELL	$4.98 - $6.63 $18,381 - $24,471	-3,691 Reduced 1.17%	310,601 $1.64 Million
Q2 2021 Aug 06, 2021	BUY	$2.56 - $5.49 $14,581 - $31,271	5,696 Added 1.85%	314,292 $1.73 Million
Q1 2021 May 10, 2021	BUY	$2.69 - $5.25 $315,055 - $614,885	117,121 Added 61.17%	308,596 $836,000
Q4 2020 Feb 10, 2021	BUY	$3.17 - $4.49 $29,176 - $41,325	9,204 Added 5.05%	191,475 $609,000
Q3 2020 Nov 13, 2020	BUY	$2.98 - $5.2 $280,471 - $489,413	94,118 Added 106.77%	182,271 $728,000
Q1 2020 May 21, 2020	BUY	$1.92 - $4.39 $8,309 - $18,999	4,328 Added 5.16%	88,153 $217,000
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $148,754 - $271,585	61,724 Added 279.28%	83,825 $339,000
Q2 2019 Aug 13, 2019	SELL	$2.53 - $3.04 $10,120 - $12,160	-4,000 Reduced 15.33%	22,101 $66,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $10,062 - $14,953	-4,009 Reduced 13.31%	26,101 $78,000
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $6,374 - $10,663	4,009 Added 15.36%	30,110 $73,000
Q3 2018 Nov 09, 2018	BUY	$1.59 - $2.42 $4,929 - $7,502	3,100 Added 13.48%	26,101 $56,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $24,107 - $49,601	-10,667 Reduced 31.68%	23,001 $52,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $118,174 - $203,354	33,668 New	33,668 $158,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account